close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Kuros Biosciences AG

News headline image
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros statement on media inquiry concerning former Board member
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences announces changes in the Board of Directors
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences Reports First Half of 2025 Results
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Annual General Meeting of Kuros Biosciences approves all resolutions
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
From Kuros Biosciences AG
Via GlobeNewswire
News headline image
Kuros Biosciences grows sales to CHF 75.6 million for 2024
From Kuros Biosciences AG
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today